• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Emergency Classics

The CARESS trial: Dual antiplatelet therapy superior to monotherapy in symptomatic carotid stenosis [Classics Series]

byAndrew Cheung, MD MBA
August 3, 2014
in Emergency Classics, General Medicine Classics, Surgery Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Dual antiplatelet therapy with clopidogrel and aspirin was associated with a significant reduction in microembolic events in patients with symptomatic carotid stenosis compared to aspirin alone

2. There was no significant difference between the two groups in the risk of bleeding

Original Date of Publication: May 3, 2005 

Study Rundown: The CARESS trial assessed how combination antiplatelet therapy with clopidogrel and aspirin compared to aspirin alone when used to prevent embolic events in patients with symptomatic carotid stenosis. The study used microembolic signals (MES) detected by transcranial Doppler (TCD) ultrasound as a surrogate marker for antiplatelet efficacy and risk of TIA or stroke.

In summary, dual antiplatelet therapy was associated with a 39.8% relative risk reduction in the proportion of patients who were positive for MES after one week of treatment (95%CI 13.8-58.0; P=0.0046). Further, the frequency of MES was significantly reduced in the dual therapy group compared to the monotherapy group and there was no increased risk of bleeding associated with combination therapy. Although the trial did not assess a clinical end point, it demonstrated that MES detected by TCD is a feasible outcome measure that does not require the large sample size necessary to assess the end point of stroke.

Click to read the study in Circulation

RELATED REPORTS

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

Personalized visual perceptual learning digital therapy may improve vision post-stroke

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

In-Depth [randomized controlled trial]: This randomized, double-blind, multicentre study involved 11 centres located in France, Germany, Switzerland, and the United Kingdom. Eligible patients were >18 years old, had ≥50% stenosis, and had TIA or stoke in the past 3 months. These patients were evaluated for MES using TCD ultrasound. Exclusion criteria include having clinical/imaging evidence of hemorrhagic transformation, carotid endarterectomy scheduled within the next 2 weeks, acoustic window that did not allow TCD recording, atrial fibrillation or other major cardiac source of embolism, thrombolysis within the last 2 weeks, and anticoagulation within the past 3 days, amongst other factors.

Patients in whom MES were detected were randomized to receive clopidogrel plus aspirin or aspirin monotherapy. Those in the dual therapy group received a loading dose of 300 mg of clopidogrel on day 1, followed by 75 mg once daily up to day 7. Both groups received 75 mg of aspirin once daily for the duration of the study. The primary end point was the proportion of patients who were MES positive on day 7. Secondary end points included the proportion of patients who were MES positive on day 2 and the rate of embolization (in number of MES per hour) on days 2 and 7.

After screening for MES with TCD, 107 patients were randomized to receive either dual therapy or monotherapy. On intention-to-treat analysis, dual therapy was associated with a significant reduction in the proportion of patients who were MES positive on day 7 (RRR 39.8%; 95% CI 13.8-58.0; P=0.0046). MES frequency per hour was reduced in the dual therapy group compared to the monotherapy group at both day 7 (embolization rate reduction 61.4%; 95% CI 31.6-78.2; P=0.001) and day 2 (embolization rate reduction 61.6%; 95% CI 34.9-77.4; P<0.001). There was no significant difference in bleeding between the two treatment groups.

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: antiplateletcarotid stenosisstrokeTIA
Previous Post

Economic incentives effective in increasing male circumcision rates in Kenya

Next Post

2 Minute Medicine Rewind July 27 – August 3, 2014

RelatedReports

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Impaired lipoprotein cholesterol ratio is associated with cognitive impairment in patients with stroke

June 4, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Personalized visual perceptual learning digital therapy may improve vision post-stroke

May 30, 2025
Stroke expansion following intra-arterial therapy may explain worse outcomes
Emergency

Delayed alteplase has clinical benefits in posterior circulation stroke outcomes

May 30, 2025
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Low-frequency electrical stimulation effective for stimulation of the wrist extensors in patients after stroke

May 24, 2025
Next Post
New dengue fever vaccine effective in phase 3 trial

2 Minute Medicine Rewind July 27 – August 3, 2014

Lower vulvar cancer-related mortality in African Americans

Severity of complications in pediatric influenza-like illness identified

No obesity paradox found between BMI, stroke, and death

Amount of electronic gameplay associated with psychosocial adjustment

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large language models show potential to provide feedback on research papers on a large-scale
  • #VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.